Natalie Pica, Ph.D. - Publications

2012 Microbiology Mount Sinai School of Medicine, New York, NY 
Virology Biology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Pica N, Bouvier NM. Ambient temperature and respiratory virus infection. The Pediatric Infectious Disease Journal. 33: 311-3. PMID 24378933 DOI: 10.1097/INF.0000000000000235  1
2013 Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of Virology. 87: 6542-50. PMID 23576508 DOI: 10.1128/JVI.00641-13  1
2013 Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annual Review of Medicine. 64: 189-202. PMID 23327522 DOI: 10.1146/annurev-med-120611-145115  1
2012 Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. Plos One. 7: e43603. PMID 22928001 DOI: 10.1371/journal.pone.0043603  1
2012 Krammer F, Pica N, Hai R, Tan GS, Palese P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. Journal of Virology. 86: 10302-7. PMID 22787225 DOI: 10.1128/JVI.01336-12  1
2012 Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. Journal of Virology. 86: 10293-301. PMID 22787224 DOI: 10.1128/JVI.01131-12  1
2012 Bouvier NM, Rahmat S, Pica N. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase. Journal of Virology. 86: 7268-79. PMID 22532693 DOI: 10.1128/JVI.07242-12  1
2012 Pica N, Bouvier NM. Environmental factors affecting the transmission of respiratory viruses. Current Opinion in Virology. 2: 90-5. PMID 22440971 DOI: 10.1016/j.coviro.2011.12.003  1
2012 Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. Journal of Virology. 86: 5782-90. PMID 22398291 DOI: 10.1128/JVI.00190-12  1
2012 Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. Journal of Virology. 86: 5774-81. PMID 22398287 DOI: 10.1128/JVI.00137-12  1
2012 Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America. 109: 2573-8. PMID 22308500 DOI: 10.1073/pnas.1200039109  1
2012 Pica N, Chou YY, Bouvier NM, Palese P. Transmission of influenza B viruses in the guinea pig. Journal of Virology. 86: 4279-87. PMID 22301149 DOI: 10.1128/JVI.06645-11  1
2011 Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, García-Sastre A, Lowen AC, Palese P, Steel J. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. Journal of Virology. 85: 12825-9. PMID 21917963 DOI: 10.1128/JVI.05930-11  1
2011 Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. Journal of Virology. 85: 11235-41. PMID 21880744 DOI: 10.1128/JVI.05794-11  1
2011 Pica N, Palese P, Steel J. Live attenuated influenza virus vaccines: Ns1 truncation as an approach to virus attenuation Birkhauser Advances in Infectious Diseases. 195-221. DOI: 10.1007/978-3-0346-0277-8_8  1
2010 Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proceedings of the National Academy of Sciences of the United States of America. 107: 18979-84. PMID 20956293 DOI: 10.1073/pnas.1013387107  1
2010 Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. Plos Pathogens. 6: e1000796. PMID 20195520 DOI: 10.1371/journal.ppat.1000796  1
2009 Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 27: 3766-74. PMID 19464560 DOI: 10.1016/j.vaccine.2009.03.090  1
Show low-probability matches.